Featured Research

from universities, journals, and other organizations

Playing A High Resistance Wind Instrument May Reduce Risk For Sleep Apnea In Musicians

Date:
June 11, 2009
Source:
American Academy of Sleep Medicine
Summary:
The naturalistic respiratory muscle training with high resistance wind instruments may potentially reduce musicians' risk for obstructive sleep apnea, according to new research.

The naturalistic respiratory muscle training with high resistance wind instruments may potentially reduce musicians' risk for obstructive sleep apnea (OSA), according to a research abstract that will be presented on June 9, at Sleep 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies.

Results suggest that instrumentalists who played high resistance, double reed woodwinds, such as the oboe, had a lower risk of OSA than other instrumentalists. No significant difference in risk for OSA was found in instrumentalists (29.1 percent) versus non-instrumentalists (33.3 percent).

According to principal investigator Christopher Ward, PhD, assistant professor of psychology and lead author Kaki York, PhD, at the University of Houston-Clear Lake, Houston, it is difficult to determine why only instrumentalists who played double reed instruments showed the least likelihood of having OSA. The reduced risk could be caused by different physiological requirements to play the instrument, or simply by lifestyle choices made by certain musician groups.

"The number of hours practiced per week seemed to be the most important variable in lowering risk for OSA. Double reed instrumentalists at low risk for OSA played their instrument 17 hours a week on average, while those at high risk only averaged 8.5 hours per week," said Ward.

The study surveyed 847 professional musicians, including 760 instrumentalists and 87 conductors/vocalists. Participants' average age was 42.5, and the majority of the sample was male (62.2 percent). Musicians had an average of 30.2 years of experience and played for an average of 15 hours a week. Of the musicians, 29.2 percent were high risk for OSA and 4.3 percent of the participants were already diagnosed with OSA.

Although future clinical trials will be needed to confirm this hypothesis, findings suggest that naturalistic respiratory muscle training with high resistance wind instruments may reduce risk for OSA in at-risk populations.

Abstract Title: Risk of Obstructive Sleep Apnea in Wind Musicians


Story Source:

The above story is based on materials provided by American Academy of Sleep Medicine. Note: Materials may be edited for content and length.


Cite This Page:

American Academy of Sleep Medicine. "Playing A High Resistance Wind Instrument May Reduce Risk For Sleep Apnea In Musicians." ScienceDaily. ScienceDaily, 11 June 2009. <www.sciencedaily.com/releases/2009/06/090609072713.htm>.
American Academy of Sleep Medicine. (2009, June 11). Playing A High Resistance Wind Instrument May Reduce Risk For Sleep Apnea In Musicians. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2009/06/090609072713.htm
American Academy of Sleep Medicine. "Playing A High Resistance Wind Instrument May Reduce Risk For Sleep Apnea In Musicians." ScienceDaily. www.sciencedaily.com/releases/2009/06/090609072713.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins